| #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospi | ohne Phasenangabe | rekrutiert |
| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indole | Phase II / Phase III | rekrutiert |
| (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointe | Phase III | rekrutiert |
| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis | Phase I | rekrutiert |
| A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed Wit | Phase III | rekrutiert |
| A Clinical Study of Arfolitixorin in Patients With mCRC | Phase I / Phase II | rekrutiert |
| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With C | Phase III | rekrutiert |
| A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) | Phase II | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID- | Phase III | rekrutiert |
| A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796 | Phase III | rekrutiert |
| A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-724 | Phase II | rekrutiert |
| A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis | Phase II | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially B | Phase I / Phase II | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemo | Phase III | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infant | Phase II | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Mi | Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic M | Phase III | rekrutiert |
| A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease | Phase II | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | ohne Phasenangabe | rekrutiert |
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patien | Phase III | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) | Phase III | rekrutiert |
| A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's | Phase II | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A Methodological Study to Learn More About Kidney Function in Healthy People and in People With | ohne Phasenangabe | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutati | — | rekrutiert |
| A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Co | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria | Phase I | rekrutiert |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy | Phase I / Phase II | rekrutiert |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Phase I | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOV | Phase II | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hyperchol | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and | Phase III | rekrutiert |
| A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanc | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | Frühe Phase I | rekrutiert |
| A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated | — | rekrutiert |
| A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, a | — | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Sup | ohne Phasenangabe | rekrutiert |
| A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) | Phase III | rekrutiert |
| A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propi | Phase III | rekrutiert |
| A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Id | Phase II | rekrutiert |
| A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in Pe | Phase II | rekrutiert |
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function | Phase II | rekrutiert |
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in | Phase II | rekrutiert |
| A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People Wit | Phase I | rekrutiert |
| A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of Pe | Phase I | rekrutiert |
| A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After | Phase I | rekrutiert |
| A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disea | Phase III | rekrutiert |
| A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A | Phase III | rekrutiert |
| A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versi | Phase I | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to | Phase IV | rekrutiert |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar | Phase III | rekrutiert |
| A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G1 | Phase II | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination Wit | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Interventi | Phase IV | rekrutiert |
| A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients | Phase IV | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients W | Phase I | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Her | — | rekrutiert |
| A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With | — | rekrutiert |
| A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Com | Phase I | rekrutiert |
| A Study With CIT-013 in RA Patients | Phase II | rekrutiert |
| A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated | Phase I | rekrutiert |
| A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated | Phase I | rekrutiert |
| A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) | Phase II / Phase III | rekrutiert |
| A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) | Phase II | rekrutiert |
| A Study of AZD0120 in Autoimmune Diseases | Phase I | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epider | Phase II | rekrutiert |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian C | Phase III | rekrutiert |
| A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platin | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Al | Phase III | rekrutiert |
| A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiop | Phase III | rekrutiert |
| A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) | Phase II | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D | Phase II | rekrutiert |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of Brenipatide in Participants With Alcohol Use Disorder | Phase III | rekrutiert |
| A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | Phase I / Phase II | rekrutiert |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | Phase I / Phase II | rekrutiert |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanc | Phase III | rekrutiert |
| A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies | Phase I / Phase II | rekrutiert |
| A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chron | Phase II / Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabe | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or | Phase III | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase II | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastat | Phase III | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro | Phase III | rekrutiert |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refra | Phase I | rekrutiert |
| A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP | — | rekrutiert |
| A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stro | Phase III | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Phase II / Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembroliz | Phase III | rekrutiert |
| A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous N | Phase II | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer | Phase I | rekrutiert |
| A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neop | Phase I | rekrutiert |
| A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic | Phase II | rekrutiert |
| A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors | Phase I | rekrutiert |
| A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 | Phase I | rekrutiert |
| A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis | Phase I | rekrutiert |
| A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adult | Phase II | rekrutiert |
| A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Phase I | rekrutiert |
| A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps | Phase III | rekrutiert |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Co | Phase II | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acal | Phase III | rekrutiert |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Phase III | rekrutiert |
| A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newb | Phase III | rekrutiert |
| A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer | Phase II | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors | Phase I | rekrutiert |
| A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide | Phase I | rekrutiert |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, | Phase I / Phase II | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembroliz | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pem | Phase III | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions | Phase II / Phase III | rekrutiert |
| A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma | Phase II | rekrutiert |
| A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-li | Phase III | rekrutiert |
| A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With | Phase III | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to S | Phase III | rekrutiert |
| A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the | Phase III | rekrutiert |
| A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refr | Phase I / Phase II | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan ( | Phase III | rekrutiert |
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel | Phase I / Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previous | Phase III | rekrutiert |
| A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart ( | Phase III | rekrutiert |
| A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, o | Phase III | rekrutiert |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking | Phase III | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) | Phase III | rekrutiert |
| A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradi | Phase III | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 | Phase I | rekrutiert |
| A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hosp | Phase III | rekrutiert |
| A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease | Phase I | rekrutiert |
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chro | Phase II | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Mo | Phase II | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migrai | Phase II | rekrutiert |
| A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participan | Phase I / Phase II | rekrutiert |
| A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEP | Phase III | rekrutiert |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients W | Phase II | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progr | Phase II | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Parti | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experience | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Re | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants Wi | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major De | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Prima | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Co | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previous | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Ado | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Y | Phase II | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intraveno | Phase II | rekrutiert |
| A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Childre | Phase III | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |